{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T15:50:41Z","timestamp":1794844241161,"version":"4.9.1"},"reference-count":83,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T00:00:00Z","timestamp":1645401600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Metabolic (dysfunction) associated fatty liver disease (MAFLD), previously known as non-alcoholic fatty liver disease, is the most common cause of chronic liver disease worldwide. Many risk factors contribute to the pathogenesis of MAFLD with metabolic dysregulation being the final arbiter of its development and progression. MAFLD poses a substantial economic burden to societies, which based on current trends is expected to increase over time. Numerous studies have addressed various aspects of MAFLD from its risk associations to its economic and social burden and clinical diagnosis and management, as well as the molecular mechanisms linking MAFLD to end-stage liver disease and hepatocellular carcinoma. This review summarizes current understanding of the pathogenesis of MAFLD and related diseases, particularly liver cancer. Potential therapeutic agents for MAFLD and diagnostic biomarkers are discussed.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cm9.0000000000002089","type":"journal-article","created":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T12:04:38Z","timestamp":1645531478000},"page":"547-556","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":82,"title":["From MAFLD to hepatocellular carcinoma and everything in between"],"prefix":"10.1097","volume":"135","author":[{"given":"Sarah Da Won","family":"Bae","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,3,5]]},"reference":[{"key":"R1-20250603","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors, and prevention","volume":"18","author":"Huang","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R2-20250603","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1097\/CM9.0000000000000981","article-title":"From NAFLD to MAFLD: a \u201credefining\u201d moment for fatty liver disease","volume":"133","author":"Zheng","year":"2020","journal-title":"Chin Med J"},{"key":"R3-20250603","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev-med-090514-013832","article-title":"Liver cancer: connections with obesity, fatty liver, and cirrhosis","volume":"67","author":"Marengo","year":"2016","journal-title":"Annu Rev Med"},{"key":"R4-20250603","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/hep.31420","article-title":"From NAFLD to MAFLD: implications of a premature change in terminology","volume":"73","author":"Younossi","year":"2021","journal-title":"Hepatology"},{"key":"R5-20250603","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.jhep.2021.04.049","article-title":"Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis","volume":"75","author":"Pinyol","year":"2021","journal-title":"J Hepatol"},{"key":"R6-20250603","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1053\/j.gastro.2019.05.064","article-title":"Toward more accurate nomenclature for fatty liver diseases","volume":"157","author":"Eslam","year":"2019","journal-title":"Gastroenterology"},{"key":"R7-20250603","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"R9-20250603","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrgastro.2013.183","article-title":"NAFLD, NASH and liver cancer","volume":"10","author":"Michelotti","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R10-20250603","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/apt.15673","article-title":"Modelling NAFLD disease burden in four Asian regions-2019\u20132030","volume":"51","author":"Estes","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"R11-20250603","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.3390\/biomedicines9101346","article-title":"Non-alcoholic fatty liver disease in lean and non-obese individuals: current and future challenges","volume":"9","author":"Kuchay","year":"2021","journal-title":"Biomedicines"},{"key":"R12-20250603","first-page":"8543763","article-title":"Molecular pathogenesis of nonalcoholic steatohepatitis- (NASH-) related hepatocellular carcinoma","volume":"2018","author":"Kutlu","year":"2018","journal-title":"Can J Gastroenterol Hepatol"},{"key":"R13-20250603","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s15010-019-01345-y","article-title":"Epidemiological and etiological variations in hepatocellular carcinoma","volume":"48","author":"Sagnelli","year":"2020","journal-title":"Infection"},{"key":"R14-20250603","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12328-014-0548-5","article-title":"Clinical features of hepatocellular carcinoma associated with nonalcoholic fatty liver disease: a review of human studies","volume":"8","author":"Oda","year":"2015","journal-title":"Clin J Gastroenterol"},{"key":"R15-20250603","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12944-020-01210-0","article-title":"Mutual interaction between endoplasmic reticulum and mitochondria in nonalcoholic fatty liver disease","volume":"19","author":"Wang","year":"2020","journal-title":"Lipids Health Dis"},{"key":"R16-20250603","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"R17-20250603","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1111\/jgh.15009","article-title":"Nonalcoholic fatty liver disease burden: Australia, 2019\u20132030","volume":"35","author":"Adams","year":"2020","journal-title":"J Gastroenterol Hepatol"},{"key":"R18-20250603","doi-asserted-by":"crossref","first-page":"E429","DOI":"10.9778\/cmajo.20190212","article-title":"Burden of nonalcoholic fatty liver disease in Canada, 2019\u20132030: a modelling study","volume":"8","author":"Swain","year":"2020","journal-title":"CMAJ Open"},{"key":"R19-20250603","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jhep.2021.05.022","article-title":"Burden of non-alcoholic fatty liver disease in Asia, the Middle East and North Africa: data from Global Burden of Disease 2009\u20132019","volume":"75","author":"Golabi","year":"2021","journal-title":"J Hepatol"},{"key":"R20-20250603","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","article-title":"Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period","volume":"69","author":"Estes","year":"2018","journal-title":"J Hepatol"},{"key":"R21-20250603","doi-asserted-by":"crossref","first-page":"e042843","DOI":"10.1136\/bmjopen-2020-042843","article-title":"Increasing prevalence of NAFLD\/NASH among children, adolescents and young adults from 1990 to 2017: a population-based observational study","volume":"11","author":"Zhang","year":"2021","journal-title":"BMJ Open"},{"key":"R22-20250603","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/1751-2980.12685","article-title":"Guidelines of prevention and treatment of nonalcoholic fatty liver disease (2018, China)","volume":"20","author":"Fan","year":"2019","journal-title":"J Dig Dis"},{"key":"R23-20250603","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/hep.30626","article-title":"Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps","volume":"70","author":"Lonardo","year":"2019","journal-title":"Hepatology"},{"key":"R24-20250603","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.aohep.2019.04.012","article-title":"Gender-specific differences in clinical and metabolic variables associated with NAFLD in a Mexican pediatric population","volume":"18","author":"Villanueva-Ortega","year":"2019","journal-title":"Ann Hepatol"},{"key":"R25-20250603","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/2470289718787091","article-title":"Female dietary patterns and the pathogenesis of NAFLD","volume":"2","author":"H\u00f6rist-Kollmann","year":"2018","journal-title":"Gend Genome"},{"key":"R26-20250603","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.clinthera.2021.01.006","article-title":"Advances in the epidemiology, diagnosis, and management of pediatric fatty liver disease","volume":"43","author":"Suri","year":"2021","journal-title":"Clin Ther"},{"key":"R27-20250603","doi-asserted-by":"crossref","first-page":"e0140908","DOI":"10.1371\/journal.pone.0140908","article-title":"The prevalence of non-alcoholic fatty liver disease in children and adolescents: a systematic review and meta-analysis","volume":"10","author":"Anderson","year":"2015","journal-title":"PLoS One"},{"key":"R28-20250603","article-title":"The burden and sexual dimorphism with nonalcoholic fatty liver disease in Asian children: a systematic review and meta-analysis","author":"Zou","year":"2021","journal-title":"Liver Int"},{"key":"R29-20250603","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12876-021-01720-w","article-title":"Economic burden of non-alcoholic steatohepatitis with significant fibrosis in Thailand","volume":"21","author":"Phisalprapa","year":"2021","journal-title":"BMC Gastroenterol"},{"key":"R30-20250603","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1002\/hep4.1599","article-title":"The growing burden of disability related to nonalcoholic fatty liver disease: data from the Global Burden of Disease 2007\u20132017","volume":"4","author":"Paik","year":"2020","journal-title":"Hepatol Commun"},{"key":"R31-20250603","doi-asserted-by":"crossref","first-page":"715","DOI":"10.4254\/wjh.v9.i16.715","article-title":"Non-alcoholic fatty liver disease: an expanded review","volume":"9","author":"Benedict","year":"2017","journal-title":"World J Hepatol"},{"key":"R32-20250603","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1002\/hep.20973","article-title":"Nonalcoholic fatty liver disease: from steatosis to cirrhosis","volume":"43","author":"Farrell","year":"2006","journal-title":"Hepatology"},{"key":"R33-20250603","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"R34-20250603","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/flgastro-2013-100403","article-title":"Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging","volume":"5","author":"Dyson","year":"2014","journal-title":"Frontline Gastroenterol"},{"key":"R35-20250603","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.dld.2021.05.014","article-title":"MAFLD vs NAFLD: where are we?","volume":"53","author":"Mantovani","year":"2021","journal-title":"Dig Liver Dis"},{"key":"R36-20250603","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jgh.14270","article-title":"Burden of non-alcoholic fatty liver disease in Australia","volume":"33","author":"Mahady","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"key":"R37-20250603","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1148\/rg.266065004","article-title":"Fatty liver: imaging patterns and pitfalls","volume":"26","author":"Hamer","year":"2006","journal-title":"Radiographics"},{"key":"R38-20250603","doi-asserted-by":"crossref","first-page":"20170959","DOI":"10.1259\/bjr.20170959","article-title":"Liver fat imaging-a clinical overview of ultrasound, CT, and MR imaging","volume":"91","author":"Zhang","year":"2018","journal-title":"Br J Radiol"},{"key":"R39-20250603","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.metabol.2015.11.008","article-title":"Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"65","author":"Brown","year":"2016","journal-title":"Metabolism"},{"key":"R40-20250603","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology"},{"key":"R41-20250603","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1097\/CM9.0000000000001888","article-title":"Non-alcoholic steatohepatitis and risk of hepatocellular carcinoma","volume":"134","author":"Rios","year":"2021","journal-title":"Chin Med J"},{"key":"R42-20250603","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s12072-020-10094-2","article-title":"The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease","volume":"14","author":"Eslam","year":"2020","journal-title":"Hepatol Int"},{"key":"R43-20250603","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/jgh.13856","article-title":"The Asia-Pacific working party on non-alcoholic fatty liver disease guidelines-Part 2: management and special groups","volume":"33","author":"Chitturi","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"key":"R44-20250603","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/hep4.1479","article-title":"Pathogenesis of nonalcoholic steatohepatitis: an overview","volume":"4","author":"Parthasarathy","year":"2020","journal-title":"Hepatol Commun"},{"key":"R45-20250603","doi-asserted-by":"crossref","first-page":"597648","DOI":"10.3389\/fendo.2020.597648","article-title":"Chronic inflammation in non-alcoholic steatohepatitis: molecular mechanisms and therapeutic strategies","volume":"11","author":"Luci","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R46-20250603","doi-asserted-by":"crossref","first-page":"149","DOI":"10.5009\/gnl.2012.6.2.149","article-title":"NASH is an inflammatory disorder: pathogenic, prognostic and therapeutic implications","volume":"6","author":"Farrell","year":"2012","journal-title":"Gut Liver"},{"key":"R47-20250603","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41575-018-0009-6","article-title":"Triggering and resolution of inflammation in NASH","volume":"15","author":"Schuster","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R48-20250603","doi-asserted-by":"crossref","first-page":"5095","DOI":"10.3748\/wjg.v11.i33.5095","article-title":"Structural and functional aspects of the liver and liver sinusoidal cells in relation to colon carcinoma metastasis","volume":"11","author":"Vekemans","year":"2005","journal-title":"World J Gastroenterol"},{"key":"R49-20250603","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1074\/mcp.M116.060145","article-title":"A cell-type-resolved liver proteome","volume":"15","author":"Ding","year":"2016","journal-title":"Mol Cell Proteomics"},{"key":"R50-20250603","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1111\/jgh.14262","article-title":"Insights into the etiology-associated gene regulatory networks in hepatocellular carcinoma from The Cancer Genome Atlas","volume":"33","author":"Seshachalam","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"key":"R51-20250603","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R52-20250603","doi-asserted-by":"crossref","first-page":"7312","DOI":"10.3748\/wjg.v20.i23.7312","article-title":"Pathogenesis of liver cirrhosis","volume":"20","author":"Zhou","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R53-20250603","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J Clin Invest"},{"key":"R54-20250603","doi-asserted-by":"crossref","first-page":"11552","DOI":"10.3748\/wjg.v21.i41.11552","article-title":"Genetic, metabolic and environmental factors involved in the development of liver cirrhosis in Mexico","volume":"21","author":"Ramos-Lopez","year":"2015","journal-title":"World J Gastroenterol"},{"key":"R55-20250603","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrgastro.2013.34","article-title":"NAFLD in Asia - as common and important as in the West","volume":"10","author":"Farrell","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R56-20250603","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.3748\/wjg.v21.i4.1189","article-title":"Characteristics of hepatocellular carcinoma in cirrhotic and non-cirrhotic non-alcoholic fatty liver disease","volume":"21","author":"Leung","year":"2015","journal-title":"World J Gastroenterol"},{"key":"R57-20250603","doi-asserted-by":"crossref","first-page":"e0124544","DOI":"10.1371\/journal.pone.0124544","article-title":"Integrative genomic signatures of hepatocellular carcinoma derived from nonalcoholic fatty liver disease","volume":"10","author":"Frades","year":"2015","journal-title":"PLoS One"},{"key":"R58-20250603","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cell.2009.12.052","article-title":"Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression","volume":"140","author":"Park","year":"2010","journal-title":"Cell"},{"key":"R59-20250603","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/cr.2010.183","article-title":"NF-\u03baB and STAT3 - key players in liver inflammation and cancer","volume":"21","author":"He","year":"2011","journal-title":"Cell Res"},{"key":"R60-20250603","doi-asserted-by":"crossref","first-page":"G794","DOI":"10.1152\/ajpgi.00390.2014","article-title":"Activation of the GP130-STAT3 axis and its potential implications in nonalcoholic fatty liver disease","volume":"308","author":"Min","year":"2015","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R61-20250603","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.3390\/ijms21041241","article-title":"Mitogen-Activated Protein Kinase (MAPK) and obesity-related cancer","volume":"21","author":"Donohoe","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R62-20250603","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.molmet.2016.06.003","article-title":"Non-alcoholic fatty liver and the gut microbiota","volume":"5","author":"Bashiardes","year":"2016","journal-title":"Mol Metab"},{"key":"R63-20250603","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.tim.2004.10.008","article-title":"Does the microbiota regulate immune responses outside the gut?","volume":"12","author":"Noverr","year":"2004","journal-title":"Trends Microbiol"},{"key":"R64-20250603","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/liv.13031","article-title":"The story of HCC in NAFLD: from epidemiology, across pathogenesis, to prevention and treatment","volume":"36","author":"Margini","year":"2016","journal-title":"Liver Int"},{"key":"R65-20250603","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/femsec\/fiu002","article-title":"Altered gut microbial energy and metabolism in children with non-alcoholic fatty liver disease","volume":"91","author":"Michail","year":"2015","journal-title":"FEMS Microbiol Ecol"},{"key":"R66-20250603","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12944-021-01440-w","article-title":"Compositional alterations of gut microbiota in nonalcoholic fatty liver disease patients: a systematic review and Meta-analysis","volume":"20","author":"Li","year":"2021","journal-title":"Lipids Health Dis"},{"key":"R67-20250603","first-page":"4948","article-title":"Germ-free C57BL\/6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism","volume":"24","author":"Rabot","year":"2010","journal-title":"FASEB J"},{"key":"R68-20250603","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1136\/gutjnl-2012-303816","article-title":"Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice","volume":"62","author":"Le Roy","year":"2013","journal-title":"Gut"},{"key":"R69-20250603","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nature12347","article-title":"Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome","volume":"499","author":"Yoshimoto","year":"2013","journal-title":"Nature"},{"key":"R70-20250603","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ccr.2012.02.007","article-title":"Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4","volume":"21","author":"Dapito","year":"2012","journal-title":"Cancer Cell"},{"key":"R71-20250603","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3945\/jn.112.172460","article-title":"Fatty liver accompanies an increase in lactobacillus species in the hind gut of C57BL\/6 mice fed a high-fat diet","volume":"143","author":"Zeng","year":"2013","journal-title":"J Nutr"},{"key":"R72-20250603","doi-asserted-by":"crossref","first-page":"590","DOI":"10.3390\/cells9030590","article-title":"Hepatocyte injury and hepatic stem cell niche in the progression of non-alcoholic steatohepatitis","volume":"9","author":"Overi","year":"2020","journal-title":"Cells"},{"key":"R73-20250603","doi-asserted-by":"crossref","first-page":"20112","DOI":"10.3390\/ijms141020112","article-title":"Role of hepatic progenitor cells in nonalcoholic fatty liver disease development: cellular cross-talks and molecular networks","volume":"14","author":"Carpino","year":"2013","journal-title":"Int J Mol Sci"},{"key":"R74-20250603","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/hep.30150","article-title":"Ductular reaction in liver diseases: pathological mechanisms and translational significances","volume":"69","author":"Sato","year":"2019","journal-title":"Hepatology"},{"key":"R75-20250603","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1053\/j.gastro.2013.11.034","article-title":"Links between hepatic fibrosis, ductular reaction, and progenitor cell expansion","volume":"146","author":"Williams","year":"2014","journal-title":"Gastroenterology"},{"key":"R76-20250603","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/hep.31056","article-title":"Increased liver localization of lipopolysaccharides in human and experimental NAFLD","volume":"72","author":"Carpino","year":"2020","journal-title":"Hepatology"},{"key":"R77-20250603","first-page":"2","article-title":"Novel high-throughput applications for NAFLD diagnostics and biomarker discovery","volume":"7","author":"Giraudi","year":"2021","journal-title":"Hepatoma Res"},{"key":"R78-20250603","doi-asserted-by":"crossref","first-page":"43238","DOI":"10.1038\/srep43238","article-title":"A multi-component classifier for nonalcoholic fatty liver disease (NAFLD) based on genomic, proteomic, and phenomic data domains","volume":"7","author":"Wood","year":"2017","journal-title":"Sci Rep"},{"key":"R79-20250603","doi-asserted-by":"crossref","first-page":"10606","DOI":"10.1038\/s41598-018-28854-4","article-title":"Non-invasive prediction of NAFLD severity: a comprehensive, independent validation of previously postulated serum microRNA biomarkers","volume":"8","author":"Lopez-Riera","year":"2018","journal-title":"Sci Rep"},{"key":"R80-20250603","doi-asserted-by":"crossref","first-page":"e8793","DOI":"10.15252\/msb.20188793","article-title":"Plasma proteome profiling discovers novel proteins associated with non-alcoholic fatty liver disease","volume":"15","author":"Niu","year":"2019","journal-title":"Mol Syst Biol"},{"key":"R81-20250603","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s12072-019-10001-4","article-title":"New drugs for NAFLD: lessons from basic models to the clinic","volume":"14","author":"Reimer","year":"2020","journal-title":"Hepatol Int"},{"key":"R82-20250603","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/17512433.2021.1884068","article-title":"An update on drug development for the treatment of nonalcoholic fatty liver disease - from ongoing clinical trials to future therapy","volume":"14","author":"Rau","year":"2021","journal-title":"Expert Rev Clin Pharmacol"},{"key":"R83-20250603","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jhep.2021.03.020","article-title":"FXR agonists for NASH: how are they different and what difference do they make?","volume":"75","author":"Kremoser","year":"2021","journal-title":"J Hepatol"},{"key":"R84-20250603","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41575-020-00408-y","article-title":"Therapeutic pipeline in nonalcoholic steatohepatitis","volume":"18","author":"Vuppalanchi","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000002089","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T19:06:45Z","timestamp":1748977605000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000002089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,21]]},"references-count":83,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000002089","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,21]]}}}